Atherosclerosis and Hyperlipidemia

Articles

Current Evidence and Future Directions of PCSK9 Inhibition

Published:

16 February 2021

Citation:

US Cardiology Review 2021;15:e01.

HDL Cholesterol and Adverse Outcomes

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):49–53

Novel Treatments for Cardiovascular Disease

Citation:

US Cardiology Review 2017;11(2):98–104.

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7